Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women. [electronic resource]
Producer: 20090814Description: 546-53 p. digitalISSN:- 1525-4135
- Adolescent
- Adult
- Anti-HIV Agents -- administration & dosage
- CCR5 Receptor Antagonists
- Cervix Uteri -- metabolism
- Cyclohexanes -- administration & dosage
- Female
- HIV Infections -- prevention & control
- HIV Seronegativity -- physiology
- HIV-1
- Humans
- Maraviroc
- Middle Aged
- Protein Binding
- Triazoles -- administration & dosage
- Vagina -- metabolism
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.